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INTRODUCTION 
Since the early observations on antimetabolites a considerable literature has 
developed  which  is  concerned  chiefly with  microorganisms and  to  a  lesser 
degree with mammals. Comparatively little has been reported on the effect of 
antimetabolites on mammalian cells in tissue culture. However, the possibilities 
of this approach have been amply demonstrated in studies on various purines 
that might interfere with nucleic acid metabolism in tumor cells as compared 
with normal mammalian cells (1). 
Because  of  the  importance  of protein  synthesis for  the  growth  of  cells, 
we have investigated the activity of certain materials which might interfere 
with protein metabolism. In particular we have studied the influence of amino 
acid analogs on the metabolism of tissue cultures of normal and neoplastic cells 
and tested their possible usefulness as antitumor agents. Antagonists of phenyl- 
alanine  were  chosen  for  the  initial  study because  the  metabolic pathways 
of this amino  acid are  more  restricted.  #-2-Thienyl-DL-alanine was  selected 
because of the extensive background of microbiological data on its antagonism 
to phenylalanine (2-6). 
This paper reports  the comparative toxicity of O-2-thienyl-DL-alanine  as a 
phenylalanlue  antagonist  in  tissue  cultures  of  various  mouse  normal  and 
tumor cells and data on the relative abilities of these cultures to utilize #-2- 
thienyl-DL-alanine for transamination. 
The  terms  thienylalanine and  thienylpyruvate  will  be  used  to  refer  to 
#-2-thienyl-DL-alanine and  #-2-thienylpyruvate respectively,  except  when  a 
comparison is made with compounds of similar structures. 
* This study was assisted by grants from the American Cancer Society, the Damon Runyon 
Memorial Fund  for  Cancer  Research,  and  the National  Cancer  Institute of  the National 
Institutes of Health of the Public Health Service. 
~: Part of this work was presented at the 42rid annual meeting of the American Association 
for Cancer Research, Inc., at Cleveland, Ohio, April 27, 1951. 
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Methods and Materials 
Tissue  Culture Texhniques.--Tissue  culture  studies  were  carried  out  with  roller  tube 
cultures  of heart,  and  of sarcoma  T-241  from  C-57  black mice. Each  tube  contained  six 
implants (approximately 2 to 4 mg. wet weight) in a clot made from 1 drop 20 per cent chick 
embryo extract and i drop chicken plasma. The cultures were fed 0.5 ml. of a medium which 
consisted  of chick embryo extract,  human  placental  cord  serum,  and  a  physiological salt 
solution  (Simms' X-6 without phenol  red)  (7)  in  the proportions  2:3:7.5.  24 hours  later 
the  compounds  were  added  in  0.5  ml.  X-6.  The  cultures  were examined  microscopically 
24 and 48 hours later and the toxic effects graded from 0 to 4+. Rounding up of the ceils, 
increase in granularity of the cytoplasm, and disintegration of cells were taken as evidences 
of a  toxic effect.  Preliminary experiments showed that  over the toxicity range  :t:  to 4+, 
the effects of twofold differences in concentration of thienylalanine could be easily distinguished 
and that near the middle of the toxicity range the effects of 1.5-fold differences in concentration 
could be distinguished. All cultures were kept in a rotor run at 10 R.e.H. at 35-37°C. 
When absorption spectra or paper strip chromatograms were desired on the culture fluids 
the method was modified since the serum and embryo extract interfered with these procedures. 
After planting,  the cultures were washed with 3  to 4  changes of X-6, each wash being for 
1/2 to 1 hour, until the plasma clot was clear and colorless.  The cultures were then fed the 
compounds dissolved in 1 ml. of X-6. Under these conditions there is little or no outgrowth of 
cells from the implants, but the implants survive and function for a few days. 
Paper Chromatography.--For paper chromatography the culture fluids were concentrated 
to one-fifth or one-tenth their original volumes and 0.005 or 0.0l ml. of concentrate used for 
each spot.  Chromatograms were developed in n-butanol-water, collidine-water, and phenol- 
water  systems,  usually  as  ascending  chromatograms.  Schleicher  and  Schuell filter paper 
No. 597 was used. 
Sources  of  Compounds.--phenylpyruvic  acid  and  ~-2-thienylpyruvic  acid  were  both 
synthesized by the method of Herbst and Shemin (8). The/3-2-thienylpyruvi¢ acid was best 
purified by recrystallization from glacial acetic acid, from which it precipitated in brownish 
yellow crystals which had a melting point of 159-161°C.  An elementary analysis gave: C 49.25, 
H  3.48; calculated, C  49.40,  H  3.55.  It gave an intense,  transient purple color with ferric 
chloride and a neutral equivalent of 172 (theoretical 170). Caguiant and Caguiant  (9) have 
synthesized B-2-thienylpyruvic acid by the condensation of 2-thienylacetonitrile with ethyl 
oxalate followed by acid hydrolysis of the resulting B-cyano-O-2-thienylpyruvate. Theyreported 
a  melting point  of 2450C. However, repeated  preparations  in  this  laboratory  have given 
melting points in the range  159-167°C. 
The O-2-thienyl-I~L-alanine used in this study was from three sources: commercial product 
(Nutritional  Biochemical Corporation),  a  sample from Dr.  Karl Dittmer of Florida State 
University, and  one synthesized in this laboratory by the method  of Dittmer et al.  (I0). 
The commercial sample contained a  small amount of a ninhydrin-positive compound which 
moved at almost the same rate as glutamic acid on paper chromatograms. It was therefore 
not used in experiments set up for paper chromatography or for quantitative work. 
Dr. Karl Dittmer also supplied samples of O-3-thienyl-DL-alanine  and O-2-furyl-DL-Manine. 
The pyridoxal phosphate was kindly supplied  by Dr. W.  W.  Umbreit of Merck and  Co., 
6-methyl-DL-tryptophan by Dr. Karl Pfister of Merck and  Co., 2-benzimidazole alanine by 
Eli Lilly and  Co., and  (5-uitro-o-phenetyl)-alanine and  (p-nitrophenyl)-alanine  by  Parke, 
Davis and Co. All other compounds were purchased from commercial sources. 
RESULTS 
Toxicity  St~s.--As shown in  Table I and Figs.  I, 2, 5, and 6, there  is  little 
difference in the toxicity of thienylalanine to heart fibroblasts  and cells  of j.  A.  JACQUEZ,  R.  K.  BARCLAY,  AND  C.  C.  STOCK  501 
sarcoma "1"-241. However, the macrophages which sometimes migrate out of 
sarcoma T-241  implants were more resistant to the action of thienylalanine. 
The  toxicity of  thienylalanine could  be  blocked  by  L-phenylalanine (Figs. 
3 and 7) but not by D-phenylalanine. 
Inhibition ratios were determined by finding the amount of L-phenylalanine 
required for half-nullification of a 4+  toxicity. Thus our inhibition ratios are 
calculated in the same way as those given by Clark and Dittmer (11).  The 
inhibition ratios from six experiments with heart and sarcoma T-241 fell in the 
range: 12 to 24 moles thienylalanine per mole L-phenylalanine. 
Effect of Other Compounds  on the Toxicity of Thienylalanine.--Since tyrosine 
and tryptophan have been shown to block the action of thienylalanine in some 
bacterial systems (3), we have tested a large number of amino acids and also 
some  possible  precursors  of  phenylalanine for  their  ability  to  prevent  the 
TABLE  I 
Toxicity of B-2-Thienyl-DL-alanine  to Heart Fibroblasts and Sarcoma  T-241  Cells in 
Tissue Cullure 
/~-2-Thienyl-DL-alanine 
aM/ml. 
o 
2.92 
5.84 
8.76 
11.68 
Heart 
o 
.4_ 
2 
3 
4 
Degree of toxicity 
T-241 
0 
1 
2-3 
3--4 
4 
toxicity of thienylalanine. Table II shows  the  relative  activity of a  few  of 
these  compounds.  We  define the  activity of a  compound as  the  inhibition 
ratio for the compound divided by the inhibition ratio for L-phenylalanine 
multiplied by 100. This assigns an activity of 100 per cent to L-phenyialanine. 
L-Leucine,  DL-isoleucine,  DL-norleucine,  DL-a-alanine,  glycine,  DL-threouine, 
L-cystine, L-cysteine, DL-aspartic  acid, L-glutamic acid, DL-valine,  L-histidine, 
L-arginine, L-lysine, glucose, acetoacetic acid, pyruvic acid, and a-ketoglutaric 
acid were inactive. 
Table H  and Figs. 4 and 8 show one striking difference between the heart 
and sarcoma "1"-241 cultures. Phenylpyruvate blocked the toxicity of thienyl- 
alanine in heart  cultures but  not in  sarcoma "1"-241 cultures.  Early in  the 
work, it was noticed that a faint reddish color appeared in the heart implants 
treated with thienylalanine but not in the sarcoma implants. This effect was 
markedly  intensified  in  the  heart  cultures  exposed  to  thienylalanine  and 
phenylpyruvate; a pink-red color now appeared in the medium and the heart 
implants took on a deep red color. An absorption spectrum of the culture fluids 502  TRANSAMINATION  OF  THIENYLALANINE  IN  VITRO 
showed a  broad, flat peak at about 500 m#. No color appeared in the T-241 
cultures; occasionally a  trace of color was detected but this was not common 
and when it did occur, the sarcoma cultures contained considerable numbers of 
macrophages or stromal fibroblasts. No color ever appeared in the absence of 
thienylalanine.  Furthermore  the  same  color appeared  in  the  heart  cultures 
when pyruvate or a-ketoglutarate was substituted for phenylpyruvate although 
neither of these two a-keto acids had any activity in blocking thienylalanine. 
Since phenylalanine was  the  only amino acid  that  blocked thienylalanine 
and since phenylpyruvate has been shown to substitute  for phenylalanine in 
some bacteria (12) and in the diet of rats (13, 14), it seemed likely that phenyl- 
pyruvate was converted to phenylalanine in the heart cultures. Whatever the 
TABLE II 
Relative Aaitqty in  Blocking the Toxicity of ~-2-Thienyl-DL-alanine 
L-Phenylalanine  ................................... 
n-Phenylalanine* .................................. 
L-Tyrosine  ........................................ 
3,4-Dihydroxyphenyl-DL-alanine  ..................... 
L-Tryptophan  ..................................... 
Phenylpyruvic acid  ................................ 
Phenyllactic acid  .................................. 
Phenylacetic acid  .................................. 
Activity in tissue cultures of 
Heart  "1"-241 
100  100 
0  0 
0  0 
0  0 
0  0 
70  0 
0  0 
0  0 
* The sample of D-phenylalanine actually had an activity of 7 per cent in both heart and 
"1"-241 cultures. However, the optical rotation of the sample was that of a mixture of 90 per 
cent D-phenylalanine and 10 per cent L-phenylalanine. Therefore we believe that the activity 
is accounted for by the L-phenylalanine present in the sample. 
explanation,  it must also account for the appearance  of a  common reaction 
product  (the  red-colored  compound)  when  thienylalanine  is  incubated  with 
a-ketoglutarate, pyruvate, or phenylpyruvate in heart cultures. Two metabolic 
reactions could reasonably account for these observations (a) a transamination 
between thienylalanine and the a-keto acid, or, (b) an oxidative deamination of 
thienylalanine  and  a  simultaneous  reductive  amination  of  the  a-keto  acid. 
In both of these reactions thienylpyruvate would be one of the reaction products 
irrespective of the a-keto acid used; phenylalanine would be a product only if 
the a-keto acid were phenylpyruvate. 
When  thienylpyruvate was  incubated  with  cultures  of  heart  or  sarcoma 
T-241,  a  red  color appeared  that  was  indistinguishable  from  that  resulting 
from the incubation of thienylalanine and an a-keto acid with heart cultures. 
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incubated in X-6 in the absence of any tissue, although color production was 
faster in the presence of tissue. Thus thienylpyruvate is an intermediate in the 
formation of the red-colored compound observed in our heart cultures. 
Paper strip chromatography of concentrates of tissue culture media provided 
further evidence for reactions (a)  or  (b).  Phenylalanine was found in culture 
fluids  from  heart  cultures  incubated  for  48  hours  with  thienylalanine  and 
phenylpyruvate but not in culture fluids from sarcoma T-241  cultures.  Simi- 
larly,  alanine  was  found  in  the  fluids  from  heart  cultures  incubated  with 
thienylalanine and pymvate but not in the fluids from T-241 cultures. Control 
cultures,  to which no additions were made, to which only thienylalanine was 
added,  and to which only the a-keto acid was added, were chromatographed 
simultaneously and the above mentioned amino acids were not found. By the 
same method,  glutamic acid was shown to  appear in  culture fluids  of heart 
cultures incubated with thienylalanine and a-ketoglutarate. The corresponding 
test  with T-241  cultures  could not give unequivocal results  since significant 
amounts  of  glutamic  acid  appeared  in  the  control  cultures.  However,  no 
detectably greater amounts appeared than in the control cultures. 
Thus cultures of mouse heart can convert thienylalanine and phenylpyruvate 
into phenylalanine and thienylpyruvate, the phenylalanine blocking the toxicity 
of unchanged thienylalanine and the thienylpyruvate undergoing a further reac- 
tion to form a red compound. This did not occur in cultures of sarcoma T-241. 
Transamination.--Proof  that the reaction involved is actually a transamina- 
tion and not a reductive amination coupled with an oxidative deamination was 
obtained by (1)  showing that pyridoxal phosphate,  the coenzyme for known 
transaminases, activates the reaction, (2) eliminating the possibility of reductive 
amination by showing that ammonia does not further the reaction,  and  (3) 
showing that the stoichiometric balance of reactants and products is in accord- 
ance  with  transamination.  A  preparation  of  liver  mitochondria  was  found 
to be very active in forming phenylalanine and thienylpyruvate from phenyl- 
pyruvate and  thienylalanine.  An  enzyme preparation  consisting of dialyzed 
mitochondria from mouse liver was therefore used for the quantitative studies. 
Preparation of Enzyme.--Homogenates of 5 to 6 gm. mouse liver in 0.25 M  sucrose (9 ml. 
per gm. liver) were prepared with a lucite homogenizer. An International Model PR-1 re- 
frigerated centrifuge was used for the separation of mitochondrial fractions. The homogenate 
was centrifuged twice at 500 g for 10 minutes to remove  nuclei and intact cells. The supematant 
was then centrifuged at 3000 g for 10 minutes. The pellet was resuspended in 0.25 M  sucrose 
and again centrifuged at 3000 g for 10 minutes. The pellet was resuspended in 10 to 20 nil. 
0.01 M  phosphate buffer (pH 7.4) and dialyzed  under nitrogen against 6 liters 0.01 M  phosphate 
buffer (pH 7.4) for 16 hours. This was followed by another 8 hour dialysis against 2 to 5 
liters fresh phosphate buffer. Visking tubing was used for the dialyses. Until immediately 
before use, all procedures with homogenates or fractions of homogenates were carried out 
in a cold room kept at 4°C. 
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in 0.05 ~  phosphate buffer at pH 7.4.  The a-keto acids were first neutralized with sodium 
hydroxide. Additions to the reaction vessels consisted of 1 ml. enzyme, 40/~x¢ thienylalauine, 
20 uM of the a-keto acid~ 20/~¢ ammonium chloride, and 20 w of the calcium salt of pyridoxal 
phosphate. When some of  the reagents were omitted,  an equivalent volume of phosphate 
buffer was  added so that the total volume was always 3.1  ml. The tubes were incubated 
in the tissue culture rotor until a deep red color appeared in some of the tubes. The reaction 
was stopped by adding 0.5 ml. 1,62 N perchloric acid and centrifuging. Most of the red-colored 
compound was precipitated with the proteins. The precipitate was washed with two  2.5 ml. 
batches of 0.162 N perchloric acid. The original supernatant and the washes were combined 
in a  10 ml. volumetric flask, neutralized with sodium hydroxide, and diluted to the mark 
with distilled water.  These solutions will be referred  to  as  solutions A.  To determine the 
amount of enzyme added to the vessels, 1 ml. of the enzyme preparation was precipitated 
with 5 ml. of cold 5 per cent trichloroacetic acid, washed with 5 per cent trichloroacetic acid, 
alcohol, alcohol-ether, and ether, and dried to constant weight. 
DettrminaKon of Amino Adds.--To a 25 ml. volumetric flask were added 0.7 ml. solution 
A, 1 ml. 2 N HC1, and 4 ml. distilled water. This was extracted with four 15 ml. batches of 
ether that had been equilibrated with 2 N HC1, to remove any remaining red color and thienyl- 
pyruvate. The solutions were then boiled to drive off residual ether and diluted to the mark 
with distilled water. Thienylalanine was then determined in the Beckman Model DU spectro- 
photometer in terms of the absorption of the thiophene ring at 233 mu. Extraction of solutions 
containing known amounts of thienylalanine showed that about 11 per cent of the thienyl- 
alanine was extracted by this procedure.  Corrections for this are made in the calculations. 
Total amino acids were determined on solutions A by the quantitative ninhydrin method of 
Moore and Stein (15). The solutions were first alkalinized slightly and boiled to drive off all 
ammonia. Reaction vessels to which no substrates or to which an ¢x-keto acid but no thienyl- 
alanine had been added, gave ninhydrin readings less than 3  per cent of the experimental 
values. Recoveries of thienylalanine by ultraviolet absorption and by the ninhydrin method 
from reaction vessels to which no a-keto acid was added, agreed to within 2 per cent. Therefore, 
the ultraviolet readings were used to determine the amount of thienylalanine remaining in 
the reaction vessels. Subtraction of the ninhydrin equivalent of the thienylalanine from the 
ninhydrin readings gave the amount of other amino acids formed in the reaction vessels. 
Determination of ~-Kelo Acids.----~-Ketoglutaric acid was determined by putting 0.02 ml. 
spots of solutions A on the base line of a filter paper chromatogram and covering these with a 
large drop of a  lukewarm (40°C.) solution of  1 rag. 2,4-dinitrophenylhydrazine per ml. 2 N 
HC1. Mter drying, another drop of this solution was put on the spots. The paper was then 
hung in a hood for 6 hours to drive off most of the HCh The chromatograms were developed 
in an n-butanol-water system.  Known  amounts of a-ketoglutarate were run on the same 
chromatograms.  The  2,4-dinitrophenylhydrazones  were  eluted  with  10  per  cent  sodium 
carbonate, alkalinized with sodium hydroxide, and measured in a Coleman Model 11 spectro- 
photometer at 432 m#. We were unable to determine phenylpyruvic acid. The 2,4-dinitro- 
phenylhydrazones of phenylpyruvate and thienylpyruvate could not be completely separated 
on filter paper chromatograms or on small columns of super-eel by the method of LePage (16). 
The  results of such an experiment with phenylpyruvate  as the c~-keto acid 
are shown in Table III.  A  similar experiment with a-ketoglutarate  is given in 
Table IV. 
Pyridoxal phosphate has a  small but definite activating effect on the reaction. 
Ammonia  has either no effect or a  slight inhibiting effect.  The  stoichiometric 
balance of the reaction is in agreement with the hypothesis that  the reaction 
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We  hoped  that  the  amount  of  the  red-colored  compound  formed  from 
thienylpyruvate could be used as a measure of the extent of transamination in 
our  tissue  cultures. When thienylpymvate is  incubated in X-6 even in the 
absence of any tissue, the red color appears.  Since thienylalanine alone does 
not give rise to color production, the formation of the red color in tissue cultures 
TABLE III 
Transamination  between  O-2-Thienyl-DL-alanlne and Phenylpyruvic Add 
Thienyl- 
alanine 
t~M 
40 
40 
40 
40 
Additions  to reaction  vessels  [l  Recoveries 
Phenyl- 
pyruvate 
uM 
20 
20 
20 
0 
Pyridoxal 
PO, 
0 
20 
NH4CI 
20  0 
20  20 
0 
Thienyl- 
alanine 
(1) 
uM 
28.4 
27.8 
29.2 
38.3 
Phenyl- 
alanine 
(2) 
t~M 
10.9 
13.9 
7.6 
0.9 
Trans- 
amination* 
(1) + (2) 
~M  per cent 
39.3  58 
41.7  61 
36.8  54 
39.2 
Dry weight of enzyme---0.9 mg. 
Incubated 17 hours at 37°C. 
* Per cent transamination is calculated from the amounts of thienylalanine disappearing, 
in terms of the L form of thienylalanine  added. 
TABLE IV 
Transamination  between  #-g- Thienyl-DL-alanine and a-Ketoglulacic Add 
Additions to vessels __  Thienyl 
Thienyl- a-Keto- Pyridoxal[ NH,C1  alanin, 
alanine  glutarlc  P04 
40120  o  I  o 
40  20  20  I  0 
40  20  20  20  32.9 
40  0  20  0  39.6 
0  20  20  0  -- 
0  20  20  20 
-  Glutamic  a-Keto- 
acid  glutaric 
(t)  (2) 
#M  ~M 
34.6  3.8 
32.7  6.0 
Recoveries 
Trans- 
aminafion 
5.6 
0.0 
0.3 
0.3 
(3) 
~M 
14.2 
13.2 
11.6 
0.0 
19.7 
19.4 
(1)+ (2)  (2) +  (3) 
~M  ~M 
38.4  18.0 
38.7  19.2 
38.5  17.2 
39.6 
--  20.0 
19.7 
27.0 
36.5 
35.5 
Dry weight of enzyme--6.7 rag. 
Incubated 5 hours at 37°C. 
incubated with  thienylalanine and an a-keto  acid is sufficient evidence that 
thienylpyruvate has  been  produced  and  therefore,  from  the  results  given 
above,  evidence  that  some  transamination has  occurred.  However,  it  was 
found that the rate of formation of  the  red-colored  compound from  thienyl- 
pymvate was higher in cultures of kidney, heart, liver, and brain in that order 
than in cultures of intestine, skeletal muscle, sarcoma T-241, sarcoma Ma 387, 
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can still use the rate of appearance of the red color to give us a  rough idea 
of  the  relative rates  of  transamination of  thienylalanine in  tissue  cultures. 
The results of such a determination are given in Tables V and VI. After plant- 
ing, the cultures were washed with X-6 to remove all the color from the clots 
and then fed  1 ml. X-6 containing 1000  "r  thienylalanine and 500  "r phenyl- 
pyruvate. After incubation for  24  and 48  hours,  the  cultures were  arranged 
in the order of increasing depth of red color. The culture with the most red 
TABLE V 
Production of Red-Colored Compound from fl-g-Thienyl-DL-alanine and Pl~enylpyrutqc 
Acid in Tissue Cultures o/Mouse Normal and Neo ~lastic Tissues 
Culture  Relative depth of red color 
~-Iear  t ................................................... 
Liver ................................................... 
Kidney  ................................................. 
Sternum ................................................ 
Skeletal muscle  .......................................... 
Pancreas ................................................ 
Cerebrum ............................................... 
Adrenal ................................................. 
Intestine  ................................................. 
Thymus  ................................................. 
Andervont hepatoma ..................................... 
Harding-Passey melanoma ................................. 
Bashford carcinoma 63 ..................................... 
Carcinoma 1025  ........................................... 
Eo 771 .................................................... 
Patterson lymphosarcoma .................................. 
Sarcoma 180 .............................................. 
Wagner osteogenic sarcoma ................................. 
Ridgeway osteogenic sarcoma ............................... 
Ma 387 .................................................. 
Sarcoma T-241  ............................................ 
2-3 
2 
1 
-4- 
-4- 
4- 
0--4- 
0--4- 
O-tr. 
O-tr. 
O-tr. 
color was arbitrarily assigned a grade of 4+  and unincubated X-6 was given a 
grade  of  zero;  the  rest  of  the  cultures were  given intermediate grades.  The 
normal mouse tissues in Table V  are  all from  C-57  black mice and the  rat 
tissues in Table VI are from Sherman strain rats. All the normal tissues tested 
showed some transaminase activity but the rat tumors and the last five mouse 
sarcomas in Table V showed little or no activity. For heart and sarcoma T-241, 
these conclusions are completely in agreement with the toxicity studies. 
The  Nature  of the  Red-Colored  Compound  Formed from  Thienylpyruvate.-- 
Incubation of thienylpyruvate with heart homogenates results in color produc- 
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occurs only  under aerobic conditions. The reaction is not affected by the addition 
of magnesium,  manganous,  cobaltous, cupric, ferrous, or ferric salts and the 
color of the product is not changed by these ions, however, addition of cyanide 
markedly  slows  down  color  production.  The  reaction  occurs  primarily  at 
neutral and alkaline pH. The depth of color after 3 hours' incubation at 37°C. 
TABLE  VI 
Production of Red-Colored Compound from ~-2-Tkienyl-vL-alanine and Phenylpyruvic 
Acid in Tissue Cultures of Rat Normal and Neoplastic Tissues 
Culture  Relative depth of red color 
Kidney .................................................. 
Liver .................................................... 
Heart  .................................................... 
Pancreas ................................................. 
Adrenal .................................................. 
Sternum ................................................. 
Cerebrum ................................................ 
Skeletal muscle ........................................... 
Murphy-Sturm lymphosarcoma  ............................. 
Flexner-Jobling carcinoma .................................. 
Walker carcinosarcoma 256 ................................. 
Sarcoma R-39 ............................................. 
4 
3 
2-3 
2-3 
2 
2 
1 
-4- 
0--~ 
O-tr. 
O-tr. 
O-tr. 
TABLE  VII 
E ffed of pH on Formation of Red-Colored Compound from $-2-Thienylpyruvic Acid 
pH  Density at 500 m~ 
3.3 
3.9 
4.9 
6.0 
7.0 
8.0 
8.8 
0.054 
0.062 
0.074 
0.117 
0.170 
0.321 
0.302 
of a 5.89 X  10  -4 ~  solution of thienylpyruvate in 0.1 ~s acetate or 0.1 M phos- 
phate buffers under a gas phase of 95 per cent oxygen and 5 per cent carbon 
dioxide is shown in Table VII. 
The red product is very insoluble below pH 4. It can be almost quantitatively precipitated 
by  saturating a  solution of it  with  ammonium sulfate and  acidifying to pH 3-4.  A  small 
sample of this colored compound has been obtained in a fairly pure state by repeated precipita- 
tion and washing at pH 3-4.  A  molecular weight determination,  by  the depression of the 
melting point of camphor, gave a  value of 310 -4- 30. Elementary analysis: C  52.10,  H  3.17, 508  TRANSAMINATION OF THIENYLALANIBVE IN VITRO 
S 26.35. This analysis agrees fairly well with the empirical formulas CuHsS203 and  Cld-InS30~. 
The structure of the compound has not yet been determined but a study of the reaction is in 
progress and will be reported in the future. 
Phenyllactate as  a  Precursor of  Phenylalanine.--As  shown  in  Table  II, 
phenyllactic acid could not block the toxicity of thienylalanine in cultures of 
mouse heart or sarcoma T-241. This was an unexpected result in view of the 
findings with phenylpyruvate, since both phenylpyruvate and phenyllactate 
can replace phenylalanine in the diet of the rat  (13,  14). The possibility re- 
mained that the ability to convert phenyllactate to phenylaianine is restricted 
to only a  few organs or that the mouse cannot utilize phenyllactate. To test 
the former, tissue cultures  of heart, liver,  and  kidney  were fed  2000  "r of 
thienylalanine and various amounts of phenyllactate. To insure that toxicity 
gradings were always made on the same cell type, two implants of heart were 
put into the kidney and liver cultures; all toxicity gradings were made on the 
fibroblasts migrating out of the heart implants. Phenyliactate was  15  to 20 
per cent as effective as L-phenylalanine in blocking the toxicity of thienylalanine 
in cultures of liver and kidney and was inactive in the heart cultures. At the 
same time, the red color appeared in the media of the liver and kidney cultures 
but not in the heart cultures. In other experiments in which mixed cultures 
were not used, heart,  brain,  skeletal muscle,  and  small intestine could not 
utilize phenyllactate whereas liver and kidney could, as judged by the ability 
of  these  tissues  to  form  the  red-colored  compound  when  incubated  with 
thienylalanine and phenyllactate. Thus the formation of phenylalanine from 
phenyllactate probably  involves  a  conversion  to  phenylpyruvate which  is 
restricted to only a  few organs in  the body, followed by transamination of 
phenylpyruvate to phenylaianine. 
Other Phenylalanine Antagonists and Substituted Alanines.--Much of our work 
on  O-2-thienyl-Dz-alanine  has  been  repeated  on  /3-3-thienyl-Dz-alanine  and 
/3-2-furyl-I)l.-alanine.  The former is slightly more toxic and the latter less toxic 
than/3-2-thienyl-Dz-alanine. Again, there was little selective damage to sarcoma 
T-241. As with/3-2-thienyl-DL-alanine, the toxicity of these compounds could 
be blocked by phenylalanine in both heart and T-241  cultures but by phenyl- 
pyruvate only in heart  cultures.  In  the heart  cultures, /3-2-furyl-DI.-alanine 
gives a  faint orange color when incubated with an a-keto acid but the/3-3- 
thienyl-Dz-alanine gives no color. 
A  number of other substituted alanines have also given colored products 
when incubated with a-ketoglutarate in heart cultures. Tryptophan, (5-nitro-o- 
phenetyl)-alanine,  (p-nitrophenyl)-alanine,  2-benzimidazole  alanine,  and  6- 
methyltryptophan all gave small amounts of color varying from tan to brown 
in hue. Presumably the reactions involved are  transamination followed by a 
further reaction of the a-keto acids corresponding to the above amino acids 
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DISCUSSION 
~-2-Thienyl-DL-alanine is specifically an L-phenylalanine antagonist for the 
mammalian cells we have studied. The toxicity of thienylalanine was blocked 
by L-phenylalanine but not by any of the nineteen other natural amino acids 
that  were  tested.  These results  are  in  sharp  contrast  to  those with  micro- 
organisms. Dittmer et al.  (3) have shown that tyrosine and tryptophan have 
some activity in preventing the growth inhibition of E. coli by thienylalanine 
and  that  leucine,  isoleucine,  and  tryptophan  have  some  activity  with  S. 
cerevisiae.  As  more antiamino  acids  are  tested,  it  will  be  interesting  to  see 
whether this difference continues to hold true. 
The mode of action of thienylalanine has  not  been determined but  there 
is good reason to believe that the toxic effects seen in tissue culture are due 
to interference with protein synthesis. Obviously, the toxicity of thienylalanine 
in the tissue cultures is not related to its ability to act as a substrate in trans- 
amination  except of  course  when  we  link  the  two  systems  by  introducing 
phenylpyruvate.  Thus  in  this  somewhat  simplified  living  system,  a  single 
compound acts as an antimetabolite in one set of reactions and as a substrate 
for another.  This  type  of  result  should  caution  us  about  accepting overly 
simple  interpretations  of  the  effect of antimetabolites  in  living  systems.  It 
suggests  the possibility  that  not  only  may an  antimetabolite  inhibit  some 
reactions and serve as a substrate for others but the products of those reactions 
in  which  the  antimetabolite is  acting  as a  substrate  may then act as anti- 
metabolites for other reactions. A complete discussion of all these possibilities 
has been given by Woolley (17). 
Our  results  have  some  important  implications  for  the  search  for  chemo- 
therapeutic agents for the  treatment of cancer. It has often been suggested 
that if one can find major differences in the metabolism of normal and neoplastic 
cells,  chemotherapeutic  agents  may  be  designed  to  damage  selectively the 
tumor cells.  From the viewpoint of therapeutics it would be important that 
this difference exist between the tumor and all  the vital organs of the body 
but a  large difference between the tumor cell and its normal homolog would 
not  always be necessary.  For the last five mouse sarcomas  in Table V  and 
the rat tumors in Table VI, we have such a difference and an example of the 
use of this difference to kill the cells of sarcoma T-241 in tissue culture, under 
conditions that do not damage the cells from heart implants.  We would not 
expect  such  a  clear  difference in  vivo.  From  the  chromatographic  results, 
we know that the phenylalanine resulting from transamination of thienylalanine 
and phenylpyruvate does not remain in the heart cells, but diffuses out into 
the  extracellular fluid.  In  vivo  then,  we  would  expect some  spillage of  the 
phenylalanine over into the  tumor.  In preliminary in  vivo  experiments with 
sarcoma T-241  we have observed some inhibition of the tumor but no such 
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serve as a  laboratory model of the  type of results we may hope  to obtain 
in the animal from a comparative study of the metabolic pathways of normal 
and neoplastic cells. 
The finding that thienylalanine and a number of other substituted alanines 
can enter transamination reactions again raises the question of the scope of 
transamination. In their early work, Braunstein and Kritzmann (18) suggested 
that  most  amino  acids  could  undergo  transamination.  However  only  two 
transaminases, glutamic-oxalacetic transaminase and glutamic-pyruvic trans- 
aminase, have been obtained in a high degree of purity, and these have a high 
substrate specificity. Cohen (19,  20)  then emphasized that in pigeon breast 
muscle and pig heart muscle transamination was limited primarily to dibasic 
a-amino and dibasic a-keto acids,  although he  also  showed that  in kidney 
and liver many of the monobasic amino acids could undergo transamination 
but at a much slower rate. Recently, work with homogenates and fractions of 
homogenates by Hird and Rowsell (21),  Rowsell  (22),  and Cammarata and 
Cohen (23) has again emphasized the importance of transamination involving 
monobasic amino acids. Our results lend further support to this view. 
Finally we should like to point up some of the advantages of combining 
tissue culture and antimetabolite studies. Not only is it possible to work out 
metabolic pathways but one can also study the organ distribution of a metabolic 
function as we have done for the conversion of phenyllactate into phenylalanine. 
SUMMARY 
In tissue cultures of C-57 black mouse heart and sarcoma T-241, ~-2-thienyl- 
DL-alanine acts specifically as a phenylalanine antagonist. 
Heart cultures can transaminate between ~-2-thienyl-DL-alanine and phenyl- 
pyruvate  to  form L-phenylalani~e and  thus  block  the  toxic  action  of  the 
remaining B-2-thienyl-DL-alanine,  whereas sarcoma T-241  cultures cannot. 
Of eleven mouse  tumors  and four rat  tumors  tested  for their  ability to 
perform this reaction, nine tumors had little or no activity. 
The/3-2-thienylpyruvic acid resulting from transamination further reacts to 
form a red compound the exact structure of which is not yet known. 
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EXPLANATION OF PLATES 
PLATE  20 
Photomicrographs  of 3  day old cultures of heart  from C-57  black mouse.  ×  I12. 
FIG. I.  Untreated control. 
FIG. 2.  Heart culture to which 2000  ~, #-2-thienyl-DL-alanine was added  24 hours 
after planting. 
FIG. 3.  Culture  treated  in same manner as that  shown in Fig. 2  but  160  ~  of t.- 
phenylalanine added at the same time. No toxic effect such as that  shown in Fig.  2 
but outgrowth not quite as extensive as in control. 
FIG. 4.  Culture treated in same manner as that in Fig. 2 but 100 ~ of phenylpyruvic 
acid added  at the same time. No toxic effect. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  96  PLATE  20 
(Jacquez el al. : Transamination of thienylalanine in vitro) PLATE 21 
Photomicrographs  of 3 day old cultures of sarcoma T-241  from C-57 black mouse. 
)<  112. 
Fro. 5.  Untreated control. 
FIG.  6.  Culture  of  sarcoma  T-241  to  which  2000  -y  ~-2-thienyl-DL-alanine  was 
added  24  hours  after  planting. 
Fro. 7.  Culture treated in same manner as that shown in Fig. 6 but 200 ~, L-phenyl- 
alanine  added  at  the  same  time.  The  toxic  effect  of  the  ~-2-thienyl-DL-alanine  is 
blocked. 
FIG. 8.  Culture treated in same manner as that shown in Fig. 6 but 200  ~ phenyl- 
pyruvic acid added  at the same time. The toxic effect is not blocked. The relatively 
undamaged  cells at  the  top  of  the  picture  are  macrophages  that  migrated  out  of 
the tumor. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 96  PLATE  21 
(Jacquez et al.: Transamination of thienylalanine in vitro) 